Literature DB >> 3315201

Radioimmunotherapy of cancer: clinical studies and limiting factors.

P W Dykes1, A R Bradwell, C E Chapman, A T Vaughan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3315201     DOI： 10.1016/0305-7372(87)90042-9

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  16 in total

1.  Quantification of transport and binding parameters using fluorescence recovery after photobleaching. Potential for in vivo applications.

Authors:  E N Kaufman; R K Jain
Journal:  Biophys J       Date:  1990-10       Impact factor: 4.033

2.  Optimal tumor targeting by antibodies: development of a mathematical model.

Authors:  M J Chappell; G D Thomas; K R Godfrey; A R Bradwell
Journal:  J Pharmacokinet Biopharm       Date:  1991-04

3.  Theoretical considerations for improving tumour targeting.

Authors:  G D Thomas; M J Chappell; P W Dykes; D B Ramsden; K R Godfrey; J R Ellis; A R Bradwell
Journal:  Br J Cancer Suppl       Date:  1990-07

Review 4.  Antibody mediated targeting of radioisotopes, drugs and toxins in diagnosis and treatment.

Authors:  C H Ford; V J Richardson; V S Reddy
Journal:  Indian J Pediatr       Date:  1990 Jan-Feb       Impact factor: 1.967

5.  Bespoke Pretargeted Nanoradioimmunotherapy for the Treatment of Non-Hodgkin Lymphoma.

Authors:  Kin Man Au; Ashutosh Tripathy; Carolina Pe-I Lin; Kyle Wagner; Seungpyo Hong; Andrew Z Wang; Steven I Park
Journal:  ACS Nano       Date:  2018-01-26       Impact factor: 15.881

6.  Immunotoxin pharmacokinetics: a comparison of the anti-glioblastoma bi-specific fusion protein (DTAT13) to DTAT and DTIL13.

Authors:  Edward Rustamzadeh; Daniel A Vallera; Deborah A Todhunter; Walter C Low; Angela Panoskaltsis-Mortari; Walter A Hall
Journal:  J Neurooncol       Date:  2006-05       Impact factor: 4.130

7.  The effect of antibody protein dose on the uniformity of tumor distribution of radioantibodies: an autoradiographic study.

Authors:  R D Blumenthal; I Fand; R M Sharkey; O C Boerman; R Kashi; D M Goldenberg
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

8.  Radioiodinated anti-hepatocellular carcinoma (HCC) ferritin. Targeting therapy, tumor imaging and anti-antibody response in HCC patients with hepatic arterial infusion.

Authors:  Z Fan; Z Tang; K Liu; D Zhou; J Lu; A Yuan; H Zhao
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

Review 9.  Immunotoxin therapy for CNS tumor.

Authors:  Edward Rustamzadeh; Walter C Low; Daniel A Vallera; Walter A Hall
Journal:  J Neurooncol       Date:  2003 Aug-Sep       Impact factor: 4.130

10.  Immunolocalisation and imaging of small cell cancer xenografts by the IgG2a monoclonal antibody SWA11.

Authors:  A Smith; R Waibel; G Westera; A Martin; A T Zimmerman; R A Stahel
Journal:  Br J Cancer       Date:  1989-02       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.